Supply Chain Intelligence about:
India
Thousands of companies like you use Panjiva to research suppliers and competitors.
| Date | Supplier | Customer | Details | 43 more fields |
|---|---|---|---|---|
| 2025-11-07 | Aurobindo Pharma Ltd. |
Aurologistics Llc
|
XXXX XX XXXXXXXX XXXXXXXXX XXXX XXXX XXX XXXX X XXXXXXXX XXXXXXXXXX XXXXXXXXXXXXX XXXX XXXXX XX XXXXXXXXXXX XXXXXXXXXXXXX XXXXXXXX XXXX XXX XXXX X X XXXX XXX XX XXXXXXXXX XX XXXXXXX XXXXXXXXXXXX XXXXXX X XXXXXX XXX XXX XXXX X X XXXX XXX XXXXXXX XXX X XXXX X X X X XX XXX XX XXXXXXX XXXXX XXX XXX XXXX XX XXX XXXXXX XXX XXXXX XX XXX XXX XXXXX XXXXXXXXXXX XXX XXXXX X XXXXXX XXXXXXX X XX XXXXXXXX XXX
|
Bill of lading |
| 2025-11-07 | Aurobindo Pharma Ltd. |
Aurologistics Llc
|
XXXX XX XXXXXXXX XXXXXXXXX XXXX XXXX XXX XXXX X XXXXXXXX XXXXXXXXXXX XXXXXXXXXXXXX XXX XXXXX XX XXXXXXXXXXXX XXXXXXXXXXXXX XXXXXX XX XX XXXXXXX XXXXXXXX XXX XXX X XXXX X X XXXX XXX XXXXXXXXXXX XXXXXXXXX X XXXXXX X XXXXXXXXXXXX XXXXXXXXX XXXXXXX XXX XX X XXXX X X XXXX XXX XXXXXXXX X XX XXXXXXX XXXXXXXXXX XXXXXXXXXXXXX XX XXXXX XXX XXX X XXXX X X XXXX XXX XXXXXXXXXX XXXXXXX XX XXXXXXXXXXX X XXXXXXXX
|
Bill of lading |
| 2025-11-07 | Aurobindo Pharma Ltd. |
Aurologistics Llc
|
XXXX XX XXXXXXXX XXXXXXXXX XXXX XXXX XXX XXXX X XXXXXXXX XXXXXXXXXX XXXXXXXXXXXX XXXXX XX XX XXXXXXXXXXX XXXXXXXXXXXXX XXXXXXX XXX XXXXX XX X XXXX XXX XXXXXXXXXX X XXXXXXXXXXX XXXXXXX XX XXXXXXXXXXX XXXXXXXX XXXXX XXXXXXX XXX XXXXX XX X XXXX XXX XXXXXXXXXX XXXXXXXXXXXX XXXXXXX XX X XXXXXXXXXX XXXXXXXXXXXXX XXXXXXX XXX XXXXX XX X XXXX XXX XXXXXXX XXX X XXXX X X X X XXX XXXXX XXXXXXX XXXXX XXX XXXXX
|
Bill of lading |
Generic drug manufacturer Aurobindo reported a 2.5% dip in FQ4’21 (to March 31) revenues as a result of lower formulated drug sales in the U.S. That is partly “due to a reduction in hospital procedures on the back of COVID-19” though requests for sales rep visits to doctor surgeries in the U.S... Read more →
The pharmaceutical industry represents India’s third largest export sector, accounting for 6% of exports in the past year. It’s been in decline, with shipments sliding 1% in dollar terms in the past year. The sector has also lagged the recent recovery in national exports. Volumes shipped have ... Read more →
The latest industry to face President-elect Trump’s attention is pharmaceutical manufacturing, where a commitment has been made to cut costs. While it is not clear how this will be achieved, the U.S. has made significant use of imported generic drugs once branded versions’ patents end. Panjiva... Read more →
U.S. imports of anticonvulsant drugs (AC), used for epilepsy, migraine and bipolar treatments, climbed 42% in October, the 18th straight increase. This was led by lamotrigine which jumped 150%. Generic drugmakers including Aurobindo Pharma, Cipla and Cadila have taken the lion’s share of the g... Read more →
En